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INTRODUCTION
Since June 17, 1969 the Department of Genetics of the Stanford
University Medical School has been working under contract NIH 69-2064
on a system designed to automate testing for HLA antigens. The major
objectives of the program have been to design and build a laboratory
breadboard of such an automated cytotoxicity testing system (ACTS), to
test and evaluate the performance of the unit, and to compare its
performance with non-automated tissue typing techniques. This final
report summarizes the work under this contract. Dr. Walter Bodmer,
now at Oxford was the original principal investigator on this program
and was directly involved in it until the end of 1970. We have accordingly
asked him for his comments on the results of the project which are
included as Appendix I.
We decided early in the project that the fluorochromatic cyto-
toxicity assay developed by Bodmer was most applicable to this work.
In this assay cell suspensions are incubated with fluorescein diacetate
(FDA). The nonflucrescent FDA passes readily through the cell wall.
Inside the cell it is hydrolyzed by intracellular esterases producing
free fluorescein. The fluorescein leaks from the cells very slowly.
As a result those cells with intact cell membranes show a yellow-green
fluorescence when illuminated with blue or long ultra-violet light. If
the cells are later incubated with serum and complement, any incompatible
serum will cause cell lysis. As soon as the cell wall is ruptured, the
fluorescein leaks out quickly and the cell is no longer fluorescent.
This loss of fluorescence is thus an indication of presence of antigen.
In the present method the cells are simply observed in a fluorescent
microscope after a suitable incubation time. The relative number of
fluorescent cells is determined. A positive reaction is evidenced by a
low fluorescent cell count. With the ACTS the cell suspension is made
to flow past a fluorescence detector and the fluorescent cell count
determined electronically. An advantage of this assay is that not all
the cells in any sample need be detected. So long as a control sample
is run, with a known compatible serum, the counts in each sample can be
compared with those in this control.
Description of Instrument
An overall view of the completed ACTS is shown in Figure 1, and a
view of the central unit, the delivery system and optical assembly, is
shown in Figure 2. The system was designed to pick up samples
sequentially from a Terasaki plate containing 60 sample cells, inject
them into a coaxial flow system, and examine the fluorescence of each
cell in the sample as it flows through filtered light from a mercury arc
source.
The entire operation is performed automatically and requires a
total of 6 minutes for the entire scan (60 samples) .
The instrument can be divided into the following basic parts:
1. Delivery System
2. Optical Assembly
3. Electronics
Figure 1
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Figure 2
1. Delivery System
The delivery system is an electromechanical assembly designed to
deliver each sample sequentially to the optical channel. A Hamilton
microsyringe is used to pick up the sample and deliver it in the optical
channel. All motions are pneumatically controlled with the exception
of the indexing of the Terasaki plate which is done with electrical
indexing motors.
Each cycle incorporates the following operations:
1. Slides Down (Injection of syringe into solution).
2. Syringe Piston Down.
3. Syringe Piston Up (Pick up of sample).
4. Syringe Piston Down (Injection of sample back into the plate
for mixing purposes).
5. Syringe Piston Up (Pick up of sample).
6. Slides Up (Withdrawal of syringe from solution).
7. Arm Rotation (Moving of sample containing syringe 90° from
the pick-up station to the optical channel station).
8. Slides Down (Insertion of syringe into the optical channel).
9. Syringe Piston Down (Injection of sample into the optical
channel).
10. Slides Up (Withdrawal of syringe from optical channel).
11. Syringe Piston Up.
12. Arm Return (Moving of empty syringe back to sample station).
(During this time an optional wash cycle may be activated to
wash out any residue of the previous sample. This cycle is
not used at present.)
During steps 7 through 12 of the above sequence the Terasaki plate
is moved so as to position the next sample at the sample station. The
sequence is achieved using a timing motor operating a set of cams. The
cams in turn activate microswitches energizing electrically operated
pneumatic valves which direct compressed air to the appropriate air
piston for the required motion. In this prototype instrument there are
a total of eight adjustable cams, which singly or in combination produce
the appropriate timing sequence for the above listed operations of the
sample delivering mechanism. Figure 3 shows a timing diagram of the
sequence and the cams that are used for each operation. Figure 4 shows
the electrical diagram for the indexing of the Terasaki sample plate
holder.
There are two modes of operation, -manual and automatic. The manual
mode enables the operator to move the plate to any one of the sixty
sample cavities of the plate. This is done by switching the AUTO-MANUAL
switch into the manual position and activating any of the four direction
push buttons (+x, -x, +y, -y) until the desired sample holder cavity is
under the syringe. Then by depressing the start button the sampling
mechanism is energized for one complete cycle. In the automatic position
the operation repeats for up to sixty complete cycles depending on the
starting coordinates. In any event at the end of the automatic cycle the
tray returns to the starting position (X,Y ). When the home position
switch is energized the cycle stops and the tray returns to its origin
(X,Y ). The x and y movements are achieved by utilizing two A-C motors
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to form an x-y coordinate moving stage. Each station is identified by
microswitches mounted on the stage. (10 microswitches for the ten
possible x positions and six microswitches for the y direction.) The
pattern of the plate scan is shown in Figure 5.
Alignment of Delivery Systems
Several basic operations must be performed initially in order to
assure proper alignment of the delivery system.
First, the travel of the syringe piston must be adjusted in order
to assure proper volume pick up. This is achieved by an adjustable
collar on the syringe holding assembly which limits the upward travel
of the syringe piston. Nominally this has been set for a total pickup
of 3.5 microliters with 6 to 7 microliters in the well.
The arm movement must be set so that at the sample pick up position
the syringe is directly above the first sample cavity. The plate
holder is constructed so as to allow additional adjusting flexibility.
The in-out motion provides the adjustment necessary for proper distance
setting from the rotational center of the arm while the up and down
motion adjusts for the proper elevation of the plate for accurate pick
up of the sample. The stop provided for the arm at the Injection
station must be adjusted so that the syringe needle falls into the
injection cavity. The optical channel holder incorporates in-out and
up-down adjustments. These adjustments provide the necessary
flexibility in alignment of the holder. Also stops are provided so as
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to permit removal of the entire optical channel assembly for cleaning
purposes and reinserting it without necessitating readjustment.
2. Optical Channel
The optical channel is shown in block diagram form in Figure 6.
The injected sample flows through the two capillary orifices of a
(2)laminar sheath flow system similar to that described in Merrill et al.
The system operates by vacuum (15 inches Hg gauge) which pulls the
solutions into a laminar stream of about 50 y in diameter which emerges
from the second nozzle into a viewing chamber.
The stream is illuminated by a beam from a 100 watt mercury arc
source focused by a dark field condenser. The second (outside) nozzle
is a 50 p glass capillary manufactured by Specialty Glass Co., and fed
as shown by an external normal saline solution reservoir. The inner
nozzle is a 75 u glass capillary manufactured by the same company. A
pool of saline fed by a separate saline reservoir is always present on
top of the inner nozzle channel. This keeps air from being drawn into
the channel during operation. It also washes off oil deposited on the
syringe needle during the pick up of the sample. A dual 30 y stainless
steel mesh filter is used in line with the inner stream in order to
prevent clogging of the inner needle by debris that might be picked up
and injected by the syringe. The sample containing the stained cells
is injected into the inner nozzle channel forming a stream which flows
inside the outside sheath through the outer nozzle. Due to the
12
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mechanical configuration and the dynamic forces exerted on the inner
stream containing the stained cells it emerges at about 20 y diameter.
When the up-stream pressures are adjusted correctly by relative elevations
of the feed containers, the cell sample is depleted within one cycle.
Thus mixing of successive samples is minimal and coincidence of
detection is reduced. Total fluid flow rate is about 1.5 ml/min.
The optics of the instrument, shown in Figure 7, are mounted on a
separate optical table. This optical table can be elevated up and down
with a chain drive mechanism. The objective portion of the microscope
which also incorporates the detector (phototube) is attached through an
x-y stage to the optical platform. The Y-adjustment is used to bring the
objective in line with the stream and the X-adjustment is used for
focusing. Z-adjustment is achieved by moving the entire optical table
with respect to the nozzle assembly.
The 100 watt Hg arc source is mounted on the optical table with
adjustments necessary to position it with respect to the back of the
condenser.
The condenser (dark field) is mounted on an x-y-z stage for
proper adjustment of the illuminating beam. Adjusting the condenser
for maximum output signal is difficult and the operator should be
familiar with dark field illumination before any attempt is made to make
these adjustments.
14
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3. Electronics
The electronics incorporated in this instrument are divided into
two systems. One includes the necessary electronics required for the
mechanical manipulation of the instrument. These are the timer unit with
the associated cams which energize the air valves for operating the
mechanical movements, and the circuitry for indexing the Terasaki plate.
The second system is associated with the detection and retrieval of the
electrical signal.
The timer, air valve and control operations have been described
briefly above. Figure 4 shows the electrical diagram of the control
unit for the Terasaki plate. All of the switching in this unit is done
with electromechanical switches (relays, microswitches). This approach
was chosen because-the high noise generated by the other electro-
mechanical devices used in this instrument meant that the control unit
had to be designed with good noise immunity and reliability.
The cycle begins with depressing the START button with the tray at
1A position. The start button energizes relay K8 which is self-holding
through contact K7?. Cam 8 switch applies a signal through K7-, K5-, K63,
K47 and K2? to X+ relay energizing the X-motor. X-relay is self-holding
through X+3, K03, K6?, and K5-,. When the tray reaches position 2 relay
KO is energized causing X+ to de-energize due to KCL contact. This
sequence is repeated through all 10A positions. When number 10 switch
is depressed relay K6 is energized through K2 and K4A . The next cam 8
signal is now directed to Y+ relay and is self-holding through Y+ , K4A , K37J j I,
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K2A~ and Switch A. When position B is reached, K2, K2A are energized
causing Y+ to stop the rotation of the motor through K2A-. Now the tray
is in 10B position in relation to the syringe. The next cam signal is
directed to the X-relay through energized K27 relay. This X-relay
drives the X-motor in the negative direction. The (X-) relay is self-
holding through X-_, K_, K67 (already de-energized due to K2_) and K57.
Thus when X-9 switch is activated, KO., causes the X- motion to stop.
Now with successive cam signals the tray moves in the X- direction on Row
B. This sequence is continuous up to the IB position. In this position
relay K5 through Kl~ and K3. is energized directing the next cam signal
through K5., to Y+ relay. This signal causes the motor X to move to row C.
When row C is reached, K3 energizes causing Y+ to drop and K5 to de-energize
position. The next cam 8 signal now is directed to X+ relay. This entire
sequence is repeated until the entire tray is canned. When the tray is
in the IF position, since K4, and K4A are energized, K7 is energized
through K4». This causes the synchronous motor to stop (K?7) and the
(Y-) relay to be energized,, through K7~. The Y-relay causes the Y motor
to run in the minus direction through its self-holding X ~ contact, K17
and K?7. This motion is continuous until row A is reached at which time,
due to relay Kl, (Kl_) relay K7 is de-energized and the cycle is
completed.
In the manual mode, SI disconnects all appropriate lines of the
automatic operation. Push-button switches SX+, SX-, SY+ and SY- are
operative and cause the tray to move in the appropriate direction when
any one is energized. When the tray reaches any of the end positions the
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corresponding switch, e.g. SX+ in the 10th position, is inoperative.
Also, SI switch is used to stop the automatic cycle at any given moment.
By returning the SI switch to the Auto-position and depressing the START
push-button switch the cycle resumes.
When SI switch is in the MANUAL position and S2 is switched to
HOME position the tray returns to the origin (1A position).
The electro-optical system, the second electronic unit, is shown in
Figure 6. The detailed drawing of the photomultiplier wiring in the
detector channel is shown in Figure 7.
The stream containing the sample is illuminated from the mercury arc
source through a BG 12 blue transmitting filter and a dark field condenser.
The cell fluorescence is detected through a GG 14 yellow barrier filter
by a 1P21 phototube. An operational amplifier with a pass band from 400
to 20000 hertz is used to amplify the electrical signals. This amplified
signal is fed into the counter and also is monitored by the oscilloscope.
The amplifier, oscilloscope, counter and phototube power supply are
standard IRL laboratory instruments.
The counter counts the fluorescence signals observed with each
sample and feeds the counts through an interface into the Instrumentation
Research Laboratory LING computer. At the beginning of the next injection
the counter is reset and the new count begins. This cycle is repeated
until the entire scan of the plate is completed. All the counts are
stored in the computer and at the end of the scan the teletype prints out
the tabulated counts.
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It would be possible to perform data-analysis on the signal
amplitudes of each sample by connecting a data analyzer at the output
of the amplifier. Histograms could be derived and other more sophisticated
data manipulations be performed by the computer depending on the character-
istics of the various samples and the desires of the researcher. All
this data could be stored in the computer memory for immediate or
future reference. Little of this type of data processing has been
performed on this contract due to lack of time and funds. However, it
seems to be quite feasible and valuable information could result from
amplitude analysis of samples under investigation.
In addition to the Figures mentioned above Figures 8, 9, and 10
are included with this report to provide sufficiently detailed working
drawings so that a second unit could be constructed if desired.
Figure 8 includes detail of the optical channel, and Figure 9 of the
slider and syringe (moving arm) and plate holder, while Figure 10 gives
a plan view of the entire unit.
19
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Figure 9
Assembly of Moving Arm and Tissue Plate Holder
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Operation
The following procedure is used for setting up and peforming an
experiment on this instrument.
1. Plug in the following components.
1.1 Oscilloscope
1.2 Counter
1.3 Light Source Supply
1.4 Computer Interface (Optional)
1.5 Teletype (Optional)
1.6 Tray Controller
1.7 Phototube Power Supply
1.8 Amplifier Power Supply
2. Turn on all instruments except the phototube power supply.
Press button to start the mercury arc lamp.
3. Make system interconnections and connect the two saline solution
reservoirs as shown in Figure 6. Turn on the vacuum. Focus and observe
the stream through the microscope eye piece (45 degree mirror in
appropriate position) and objective (filter removed). If no stream is
visible after the system is in focus, the detector channel orifices are
plugged and the optical channel assembly must be cleaned. If a stream
is visible, move the optical table (Z adjustment) so that the glass
capillary tube is just outside the field of view. Adjust the light
source housing so that the back of the condenser is entirely flooded
with light. Observing the stream through the eyepiece adjust the dark
field condenser so that a dark, diffuse spot is located with its center
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on the flowing stream. For this adjustment the Z and Y axis of the
condenser stage must be used. When this is achieved move the condenser
back and forth with the X-adjustment of the condenser stage while viewing
through the eyepiece until the dark spot diminishes and a bright dot
intercepts the liquid stream. When the spot appears to be the brightest
possible the optical system is aligned properly. Insert the objective
filter in position and refocus. Place a tray on the sample holder with
a fluorescein solution (10 molar) and depress the start button on the
tray controller (Auto-manual switch is in Auto position). Observe the
stream. Immediately after each injection a yellow green line should
appear in the field of view, becoming narrower with time and almost
disappearing before the next injection. If the duration of this line is
too long or too short adjust the elevation of the outer supply reservoir
until the injected solution (fluorescein) nearly disappears before .the
next injection. Turn the phototube supply on (be sure the objective
filter is in position) rotate the mirror on the microscope stage to the
phototube position and observe the signal on the oscilloscope derived by
the injection of the fluorescein into the channel. The counter at this
point should show a large count (in the thousands). Readings should be
reproducible within a few percent from one well to the next, and the
signal on the oscilloscope should show a general increase in the signal
level while the fluorescein is passing by, rather than large amplitude
spikes (if this is not the case, adjust Z position of optical channel,
and if necessary disassemble and clean the nozzle). Now return the tray
in its home position and place the tray to be assayed in the tray holder.
The instrument is now ready for operation.
24
Engineering Aspects and Evaluation
As with most new instruments, this equipment has required extensive
trouble shooting and many modifications during the process of development.
There has been a tendency for the small nozzles in the optical channels
to clog. Sometimes this results in a flow stoppage which is easily
detected and can be quickly remedied by the technician operating the
unit. However at other times there is only a partial clog which results
in erratic operation. In this case erroneous counts may be generated.
Unfortunately there is no easy way to tell if such a partial clog has
occurred.
It is necessary to cover the samples with an immiscible fluid of low
vapor pressure to prevent evaporation of the suspending liquid. Some of
this cover fluid clings to the outside of the syringe and is washed off
into the optical channel. When heavy mineral oil was used as this fluid
the instrument would clog quickly, presumably because high viscosity
globules of oil became lodged in the nozzles. Use of a lighter mineral
oil (#3 mineral oil: Van Waters & Rogers) minimized this problem,
particularly when most of the oil was removed with a Pasteur pipette
before analysis to minimize oil contamination. However use of any oil
seemed to reduce the number of counts for a given sample slightly with
respect to the count when no cover oil was used.
A wash cycle after each sample injection was included in the
original designs. However during the initial debugging procedure
various syringes were tried in an effort to get satisfactory operation,
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and the most successful was not set up mechanically for the wash cycle.
Later an attempt was made to change the syringe so as to reintroduce
the cycle, but proper adjustment proved difficult and time consuming.
Rather than delay the testing program we decided to continue without the
wash since most of the required data could be obtained using alternate
wells, filled with Hanks solution, as a wash.
It is sometimes difficult to set the signal threshold properly.
(The threshold is the signal amplitude signals must exceed to be counted.)
The cells give signals whose amplitude varies considerably. Superimposed
on these signals is background noise generated by statistical variations
in the number of quanta striking the phototube. This background noise is
low when most of the fluorescein is in the cells. It is higher when the
cells lyse and the fluorescein is in solution. As cells lyse the number
of cells giving signals above the threshold level decreases, but the number
of spurious signals from the background may increase if the threshold
is set too low. In such & case it may be hard to discriminate b&tween
positive and negative responses.
It appeared that this condition could be improved if a more intense
light source was used. Consequently tests were made comparing character-
istics of the signals from a suspension of cells run through this unit,
illuminated by its mercury arc, with those from the same suspension run
through a similar optical system illuminated by an argon ion laser. The
laser used (Coherent Radiation Model 54) is capable of increasing, the
effective illumination by between one and two orders of magnitude.
26
Results of these tests are shown in Figure 11. Curve A in this
figure shows the pulse height distribution of signals from the laser
illuminated system for a cell suspension incubated for 2 1/2 hours with
a serum with which it was not expected to react. (By pulse height
distribution we mean a plot of signal amplitude on the x axis versus a
number of signals in a given narrow amplitude range on the y axis.) It
is obvious from this plot that there is a wide distribution of signal
amplitudes. Curve B shows the pulse height distribution for the same
cells incubated with an incompatible serum for the same time. The large
difference between the two curves indicates that threshold setting would
not be critical. The threshold can be visualized as a vertical line
adjustable to any point along the x axis. The relative number of counts
is given by the area of the curve to the right of the line. No matter
where the line is positioned the area under curve A is going to be many
times the area under curve B. Results of similar tests of the present
system using the mercury arc are shown in curves C and D where curve C
represents negative reaction, and curve D positive reaction. Most of
the "signals" near the origin are probably caused by noise spikes. It
is obvious that here the position of the threshold could be very crtical.
It is probably desirable to move the threshold to the right for greatest
differentiation between the two speciments but the total count falls
rapidly when this is done and may be two low to be statistically
meaningful. Thus the threshold adjustment must be made carefully and
the proper setting may vary from sample to sample. This is undesirable
in an instrument to be used in a clinical laboratory setting. In our
27
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judgment future work with this unit might well include funds for
replacing the mercury arc source with a reasonably powerful blue laser.
The electro-pneumatic drive system used in the ACTS requires rather
delicate adjustments to function properly. In addition it is difficult to
change the operating cycle and some desirable adjustments cannot be made
at all. If we had h^ .n able to build a second system, as we originally
proposed, we would probably have chosen to use an all-electric system
with stepping motors rather than pneumatic actuators. Such systems are
capable of almost infinite flexibility, and are easily adapted to computer
control. Such flexibility would have increased the efficiency of our
experimental design work markedly. In addition the system would be
easily adaptable to such related tasks as dispensing fluids into the
Terasaki trays, removing supernatant after incubation, and incorporation
of wash cycles. It would also make it possible to vary the timing of the
sample injection into the optical channel, and thus minimize disturbance
of the sheath flow.
A set of runs were made in an effort to determine the length of time
reliable operation could be maintained. Previous to these runs our
subjective opinions were that clogging problems occurred every few plates.
That may be true at times; however during the reliability tests the
instrument operated quite reliably. Tests were run on six different
days. One day we had trouble removing an initial clog but after it was
removed the instrument ran through all six trays prepared without
trouble. A third day there was a partial clog after five plates. The
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three other days no clogs were experienced while running through all
the trays available - six trays pne day, eight another, and nine the
third. An average of eight to ten trays between clogs should be
possible after the unit was placed in routine operation, but care would
have to be used to keep dirt out of the system. Operation in filtered
air, using "clean room" techniques, would be desirable.
If we were initiating system development now we would seriously
consider eliminating the present optical channel, observing the samples
directly in the Teraaaki plate wells. This would require a rather
complicated mechanical scan if we had to observe individual cells.
However it should be possible to provide the needed information by
observing the total fluorescent output from the sample after withdrawing
and discarding the supernatant. The cells tend to stick to the bottom
of the well, and so should remain behind while the supernatant is
removed. Thus high total fluorescence should correlate with high counts,
in the present system. In this case a speeded up version of the present
mechanical movement of the Terasaki plate could be used resulting in
faster system operaton, and the clogging problems associated with the
present pickup and delivery system would be eliminated.
Biological testing and evaluation
At the beginning of the test period we planned to conduct tests in
thirteen biological areas. These areas, together with results, when
available, are discussed below. Many of them,-of course, overlap the
engineering problem areas discussed above. It should be noted that only
selected results can be shown. A total of several hundred trays were
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run through the machine in over five months of biological testing,
interrupted only when shutdowns were imposed by instrumental problems.
1. Study the carryover of serum from well to well both in oil
and without oil on the plate.
Table 1 shows typical performance with respect to carryover both
with and without oil. Column 1 gives total counts from wells without
an oil cover containing supposedly identical numbers of fluorescent cells.
Column 2 shows counts from succeeding wells without cells. It can be
seen that in this case on the order of 20% of the cells were carried over
from one injection to the next. Similar results are shown in columns 3
and 4 showing performance under #3 mineral oil.
When a second well without cells was sampled the count dropped in
about the same ratio. For example there were two blank wells after the
fifth sample in each case above. The counts were 52 and 30 respectively.
Carryover shown in Table 1 is slightly higher than typical. A
later analysis of several trays under oil indicated that, as long as
cell counts were of the order of several hundred, mean carryover was
between 10 and 15%. Relative carryover increased at lower count rates,
but absolute carryover decreased. It was seldome over 20% for a
properly functioning system when count rates on wells containing cells
remained above 200, a properly functioning wash cycle would eliminate
any carryover problem.
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Table 1
and
 Without
No
 Oil Cover
with
Cells
853
918
916
1026
925
856
937
1050
902
Succeeding1-1 , 5
v/o Cells
222
222
202
246
232
142
211
231
181
Oil cover
Wells with
Cells
654
623
642
648
712
617
642
682
662
Succeeding
Wells w/o Cells
132
136
134
164
162
114
125
112
102
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2. Study degree of reproducibility.
Reproducibility, as illustrated in Table 1, was often very good so
long as observations were made on a given sample with the same incubation
times. Count rates on all samples, even controls using compatible sera,
usually went down with time, as the fluorescein slowly leaked out of the
cells. However on a given run variations in count rates of more than
about i: 20% for samples with counts of over 100 per prima facie evidence
of instrumental problems.
3 and 4. Study the effect of varying incubation time, serum
volume, and serum strength on the results of the tests.
Table 2 shows average results for a typical series of tests over a
period of time using two different amounts of serum. As shown in the
table relative strong reactions are usually well underway within an
hour. Other tests have shown readable difference after only 30 to 40
minutes incubation. The counts with respect to control on the positive
sera decrease with time but are relatively constant between one and a
half and two and a half hours.
As shown in Table 3 the relative strengths of sera may be different
in the ACTS than with visual methods. The serum graded moderate to weak
by visual observation appeared to be very strong in the instrument.
Also this serum appeared to give better results at a lower concentration
than at a higher one.
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Table 2
Mean cell count (% of control) as a function of time of incubation,
volume and strength of serum. Test conditions: 1 yl of cells and 4 yl
complement, room temperature incubation.
Serum Strength vs
HLA5 Antigen
(Manual method)
Strong (1027D)
Strong (1063C)
Serum
Volume (yl)
1
2
1
2
Moderate to weak (1079A) 1
2
Weak (1100C) 1
2
Incubation Time (hrs.)
1_
53
33
77
65
22
39
96
93
1.5
25
30
45
34
19
25
92
104
2
17
31
24
28
13
41
93
99
2.5
21
27
19
21
21
24
92
80
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Table 3
Effect of Serum Volume
Test conditions: 1 pi cells, 5 pi complement,
room temperature incubation for 2 hours.
Antiserum Specificity
HLA1+, 2-
Volume yl Counts Relative to Control
HLA1- 2+ Cells HLA1+ 2- Cells
1
2
95
81
8
4
HLA1-, 2+ 1
2
14
11
87
75
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In the tests recorded in Table 2 one yl of serum usually took
longer to react but gave slightly lower final counts than two )jls. On
the other hand many tests like those shown in Table 3 below indicate
that counts relative to controls are lower with two ul. Our general
conclusion is that there is little real difference in final counts at
1 1/2 to 2 1/2 hours so long as the volume of serum is not so small as
to prevent reaction, but reaction is slower at lower serum volumes.
5. Study variations in volume of complement with respect to
amount and source.
This area was considered to be of low priority. There was some
variation in amount of complement used, usually to keep total volume
constant, but no specific tests were conducted on volume and kind of
complement.
6. Study the variation in FDA concentration and time of FDA
incubation.
This was important since, as discussed above (page 27), machine
sensitivity was marginal and required maximum fluorescein content in the
cells. We found it necessary to treat frozen cells with FDA after
thawing, even if they had been treated before freezing. Our optimum
procedure, arrived at after a number of tests, was to treat the cell
suspension at a concentration of about 4000 cells per microliter with
enough of a 1/2% solution of FDA in acetone to make the final FDA
concentration about 10 parts per million, incubate for fifteen minutes
at room temperature in the dark, spin down, and resuspend the pellet in
Hanks solution with 3% BSA to approximately the original concentration.
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This procedure gave good cell fluorescein content without leaving
excessive fluorescein in the diluent.
7. Study the effect of elimination of BSA from the diluent, since
it has been reported that it may inhibit FDA uptake.
Comparisons were run but no consistent inhibition was found.
Since BSA does help protect the cell wall integrity, most of our testing
was conducted with 3% BSA in the diluent.
8. Study the sensitivity of the method with respect to titers as
compared with the manual method.
Only preliminary work was done in this area. No conclusive results
were obtained. In order to study these phenomena fully an extensive
testing program would be required. Unfortunately the instrument
reliability is not high enough to make such an extensive program meaningful
at present, particularly in view of the amount of time and money which
would be needed to complete it.
9. Study the sensitivity of the method for the cross match in
kidney transplants.
Our major hope in the preliminary stages of development was that
the unit would be able to detect weaker interactions than was possible
with standard techniques .t and in fact preliminary tests on a non-automated
system indicated this would be the case (3). However, tests made with
weak sera on the ACTS unit showed no obvious improvement over visual
methods. It would be desirable to repeat these tests with a laser light
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source, giving a higher signal to noise ratio, to determine if under
these conditions the expected improvement in detection would occur.
10. Compare the routine cytotoxicity with the automated one and
with the inhibition method of Dr. Lucas. Comments under items 8 and 9
apply here.
11. Study the effect of Ficoll prepared cells as compared to the
dextran sedimented cells. (Comments under item 8 apply here.)
12. Search for other oils since the routine mineral oil does not
function well.
As noted on page 13, #3 mineral oil is much more suited to the
requirements than the heavy mineral oil previously used. Another even
lighter oil, essentially a purified kerosene, also gave acceptable
results, but was more difficult to use, since the oil splashed out of
the wells during the mixing cycle prior to sample pickup.
14. Compare manual phenotype versus phenotype obtained using the
machine.
A start was made at machine phenotyping. However the problems
listed above prevented its completion. Some differences might be
expected between ACTS and routine methods, in view of the differences in
apparent serum strengths noted.
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GENERAL CONCLUSIONS
As a result of the tests to date it appears that:
1. The system can detect strong reactions quite readily in less than
one hour. Weaker reactions may take about as long as the two to
two and one-half hours usually used in the non-automated tests.
When 1 yl of serum is used, weak reactions are probably not detected
any more readily than with visual observations. Higher concentra-
tions of serum (2 ul are used in most of the visual work) might
improve this situation. Use of a strong light source (laser),
giving a higher signal-to-noise ratio, would probably also be
helpful.
2. The system will usually operate for several plates without trouble.
However there is no assurance that it will do so and it is sometimes
difficult to determine whether the readings are correct. Most
problems have to do with clogging of the small nozzles in the flow
system.
3. The system is limited to some extent by the fact that the threshold
must be set near the noise level, so that sometimes noise pulses
are mistaken for cells. As mentioned above, a more powerful laser
light source would be helpful in this regard.
39
4. There are a number of delicate adjustments which require special
skill. The combination of this with the clogging and threshold
problems indicate that while the system is promising and could
eventually provide a very worthwhile addition to the tissue typing
field, especially if certain relatively minor modifications can be
made, it is not yet ready for widespread clinical use.
5. If further development work is possible the following specific
steps should be considered.
a. Substitution of a laser light source for the mercury arc
source, as mentioned on page 15.
b. Conversions of the drive mechanisms from the present electro-
pneumatic actuator to computer controlled stepping motors as
mentioned on page 16.
c. Elimination of the present delivery system, and observation
of the total sample directly on the Terisaki plate, as mentioned
on page 30.
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APPENDIX I
The achievements of the project and the extent to which it has met
its desired goal are clearly and fully discussed in the main body of the
report. I think the results demonstrate the feasibility of constructing
a fully automated cytotoxicity typing system more or less along the lines
we had originally envisaged, even though it did not prove possible to
produce a fully operational system by the end of the contract period.
As work on the system has progressed it has become clear that there are
several modifications in the design as originally envisaged which would
be desirable. Perhaps the major one, as indicated in the report, is to
change from an electromechanical system with pneumatic actuators to an
all electric system using computer controlled stepping motors. Other
possibilities mentioned in the report include the use of a laser as the
light source" and the possibility of a mechanical scanning system for
direct optical reading through the wells of the microtest plate without
removal of the cells. I think it should be mentioned that a major reason
for not having produced a fully operational system was the lack of
funds, rather than the lack of time. I think that it is probable that,
had we been funded for building a second prototype, this could have been
done incorporating at least some of the suggested modifications, while
at the same time allowing more intensive investigation of the properties
of such a system as far as the biological testing was concerned. I
believe that this principle of parallel development on the engineering
and the biological side of such projects is a most important one, and
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that although the initial sum of money to be spent may be more, the
overall return on the investment may turn out to be substantially
greater in the long run.
It is my feeling that many of the remaining problems of the system
could be solved with the greater flexibility of a stepping motor
controlled mechanical sampling device. Simple changes in the program,
which could be done using computer software, could deal with the intro-
duction of appropriate washing cycles, the removal of supernatant fluid
, before reading (which might substantially reduce the background and so
avoid the need for a laser light source) and appropriate cleansing
cycles to deal with the clogging problem. There is no doubt that the
use of a laser would greatly increase the resolution of the system and
that this would be extremely valuable for research purposes. The
increased price, however, may not fully justify such a development if it
were possible to achieve satisfactory results as indicated above. Any
system which involves a direct reading through the wells of the Terasaki
plates would, of course, be a great simplification. The difficulties
in this case are connected with the problems of the background fluorescence
in the fluid in which the cells are suspended and the problems of
overlapping cells if an accurate cell count is desired from a scanning
approach. This latter factor may not be important if one simply wants
a quantitative measurement which is well correlated with the number of
fluorescing cells. The former problem may be alleviated by removing the
supernatant fluid before reading, in such a way as to leave the majority
of the cells in the well. In this case it may even not be necessary to
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have the mechanical scanning device. It may then be possible simply to
take a direct reading through the well.
I think it is worth emphasizing that the approach to sampling
from a Terasaki plate which we have used may have many applications quite
apart from that to tissue typing. I believe that the use of the micro-
test plates in such a system could be viewed as part of a programable
automatic fraction collector and dispenser that disposes of the rather
clumsy devices presently used with tubes for fraction collection. The
output of material collected from the wells may, for example, be
analysed for cell counts or for radioactivity in a variety of ways.
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